Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News AI in cardiology: A step-by-step guide to developing high-quality algorithms Artificial intelligence (AI) has been one of the biggest stories in healthcare for years, but many clinicians still remain unsure about how, exactly, they should be using AI to help their patients
News Dr Pavlovic appointed as Editor in Chief of the Journal of Molecular and Cellular Cardiology PLUS
News Heart surgery and impact on mental health among new priorities for congenital heart disease research
11 June 2020 Reader in Cardiovascular Immunology joins the Institute of Cardiovascular Sciences Dr Ingrid Dumitriu has joined the Institute of Cardiovascular Sciences from St George's, University of London
03 June 2020 Birmingham professor awarded Weizmann Institute joint programme grant Professor Dirk-Peter Herten at the ICVS has received the Weizmann-UK Joint Research Programme Award to improve spatial resolution and quantitative assessment of fluorescently labelled proteins in cells
26 May 2020 Birmingham researcher wins Programme Grant from the National Institutes of Health Dr Neil Morgan has been awarded a (Multi PI) R01 Programme Grant from the National Institutes of Health (USA) to research the role of the SLFN14 gene in megakaryopoiesis and platelet development.
20 April 2020 Global virtual forum keeps heart research going during COVID-19 lockdown A series of live webinars aimed at connecting the global community of cardiovascular researchers are attracting thousands of scientists and clinical doctors from around the world.
17 March 2020 New leadership for the Institute of Cardiovascular Sciences Professor Roy Bicknell has taken over from Professor Paulus Kirchhof as Director of the Institute of Cardiovascular Sciences, supported by two Deputy Directors, Professor Ed Rainger and Dr Victoria Heath.
20 February 2020 Birmingham named one of just six new Life Sciences Opportunity Zones The Birmingham Health Partners ecosystem has been awarded Life Sciences Opportunity Zone status by the Department for Business, Energy and Industrial Strategy.
06 February 2020 Institute Early Career Researcher awarded first grant Post-Doctoral researcher Dr Molly O'Reilly has been awarded a Research Development grant in order to investigate neuromodulation of ischaemia/reperfusion-induced arrhythmia.